rs200516164

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PP3_ModerateBP6BS2

The NM_001458.5(FLNC):​c.7289C>T​(p.Ala2430Val) variant causes a missense change. The variant allele was found at a frequency of 0.000124 in 1,612,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

FLNC
NM_001458.5 missense

Scores

4
7
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:10B:2

Conservation

PhyloP100: 4.13
Variant links:
Genes affected
FLNC (HGNC:3756): (filamin C) This gene encodes one of three related filamin genes, specifically gamma filamin. These filamin proteins crosslink actin filaments into orthogonal networks in cortical cytoplasm and participate in the anchoring of membrane proteins for the actin cytoskeleton. Three functional domains exist in filamin: an N-terminal filamentous actin-binding domain, a C-terminal self-association domain, and a membrane glycoprotein-binding domain. Mutations in this gene are a cause of cardiopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2022]
FLNC-AS1 (HGNC:53474): (FLNC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.893
BP6
Variant 7-128856555-C-T is Benign according to our data. Variant chr7-128856555-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 197502.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=7}. Variant chr7-128856555-C-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLNCNM_001458.5 linkc.7289C>T p.Ala2430Val missense_variant Exon 44 of 48 ENST00000325888.13 NP_001449.3 Q14315-1Q59H94
FLNCNM_001127487.2 linkc.7190C>T p.Ala2397Val missense_variant Exon 43 of 47 NP_001120959.1 Q14315-2Q59H94
FLNC-AS1NR_149055.1 linkn.103-3158G>A intron_variant Intron 1 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLNCENST00000325888.13 linkc.7289C>T p.Ala2430Val missense_variant Exon 44 of 48 1 NM_001458.5 ENSP00000327145.8 Q14315-1
FLNCENST00000346177.6 linkc.7190C>T p.Ala2397Val missense_variant Exon 43 of 47 1 ENSP00000344002.6 Q14315-2
FLNC-AS1ENST00000469965.1 linkn.103-3158G>A intron_variant Intron 1 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152218
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000101
AC:
25
AN:
246700
Hom.:
0
AF XY:
0.0000894
AC XY:
12
AN XY:
134196
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000869
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000197
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000127
AC:
186
AN:
1460596
Hom.:
0
Cov.:
33
AF XY:
0.000124
AC XY:
90
AN XY:
726712
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000894
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000192
Gnomad4 NFE exome
AF:
0.000162
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152218
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74364
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000176
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000124
Hom.:
0
Bravo
AF:
0.000110
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000238
AC:
2
ExAC
AF:
0.0000908
AC:
11
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:10Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:7Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 01, 2020
CeGaT Center for Human Genetics Tuebingen
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 17, 2015
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 27, 2023
Revvity Omics, Revvity
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 23, 2020
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Reported in two probands with HCM; one of these probands also demonstrated elevated CK levels, and two out of three relatives who were heterozygous for A2430V demonstrated elevated CK levels and left ventricular wall measurements of 12 mm and 14 mm, respectively (Valdes-Mas et al., 2014; Gomez et al., 2017); In silico analysis supports that this missense variant does not alter protein structure/function; Published functional studies suggest an effect on protein structure (Valdes-Mas et al., 2014); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 197502; Landrum et al., 2016); This variant is associated with the following publications: (PMID: 26555887, 28356264, 25351925) -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jun 15, 2022
Clinical Genetics Laboratory, Skane University Hospital Lund
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1
Apr 10, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: FLNC c.7289C>T (p.Ala2430Val) results in a non-conservative amino acid change located in the 22nd filamin/ABP280 repeat (IPR001298, UniProt) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0001 in 246700 control chromosomes, predominantly at a frequency of 0.0002 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 18-fold of the estimated maximal expected allele frequency for a pathogenic variant in FLNC causing Cardiomyopathy phenotype (1.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.7289C>T has been reported in the literature in individuals affected with Hypertrophic Cardiomyopathy (e.g. Valdes-Mas_2014, Gomez_2017, Schanzer_2021), where in one family the variant seemed to segregate with the phenotype (Valdes-Mas_2014), and in another patient the cardiac histology was consistent with myofibrillar myopathy, but segregation analysis was not possible in this family (Schanzer_2021). These data indicate that the variant maybe be associated with disease. At least one publication reported experimental evidence evaluating an impact on protein function and demonstrated increased protein aggregation, and mislocalization to the perinuclear region in rat cardiac myoblasts transfected with the variant (Valdes-Mas_2014). The following publications have been ascertained in the context of this evaluation (PMID: 28356264, 31641117, 33710525, 25351925, 37937776). ClinVar contains an entry for this variant (Variation ID: 197502). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Uncertain:1
Nov 18, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.A2430V variant (also known as c.7289C>T), located in coding exon 44 of the FLNC gene, results from a C to T substitution at nucleotide position 7289. The alanine at codon 2430 is replaced by valine, an amino acid with similar properties. This variant has been reported in individuals with hypertrophic cardiomyopathy (HCM) and, in one family, showed limited segregation with HCM and elevated creatine kinase (Valdés-Mas R et al. Nat Commun, 2014 Oct;5:5326; Gómez J et al. Circ Cardiovasc Genet, 2017 Apr;10; Schänzer A et al. J Muscle Res Cell Motil, 2021 06;42:381-397). Studies of myocardial tissue from an affected individual with this variant and neonatal rat cardiomyocytes expressing this variant demonstrated abnormal protein aggregates (Valdés-Mas R et al. Nat Commun, 2014 Oct;5:5326; Schänzer A et al. J Muscle Res Cell Motil, 2021 06;42:381-397). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.099
T
BayesDel_noAF
Benign
-0.11
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T;.
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Pathogenic
0.29
D
MetaRNN
Pathogenic
0.89
D;D
MetaSVM
Uncertain
0.073
D
MutationAssessor
Benign
1.0
L;.
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-1.9
N;N
REVEL
Pathogenic
0.82
Sift
Benign
0.69
T;T
Sift4G
Benign
0.11
T;T
Polyphen
0.87
P;P
Vest4
0.88
MVP
0.70
MPC
0.94
ClinPred
0.16
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.12
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.32
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.32
Position offset: 8

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200516164; hg19: chr7-128496609; COSMIC: COSV57951519; API